Resisting weight gain with prebiotic fibre

Matthew M. Carter,Sean P. Spencer

DOI: https://doi.org/10.1038/s42255-024-00998-w

IF: 19.865

2024-02-28

Nature Metabolism

Abstract:Resistant starch is a prebiotic fibre that is fermented by the gut microbiota and leads to benefits for host physiology. A clinical trial in Nature Metabolism demonstrates weight loss when resistant starch was given to individuals with excess weight.

endocrinology & metabolism

What problem does this paper attempt to address?

Resistant Starch Intake Facilitates Weight Loss in Humans by Reshaping the Gut Microbiota

Huating Li,Lei Zhang,Jun Li,Qian Wu,Lingling Qian,Junsheng He,Yueqiong Ni,Petia Kovatcheva-Datchary,Rui Yuan,Shuangbo Liu,Li Shen,Mingliang Zhang,Bin Sheng,Ping Li,Kang,Liang Wu,Qichen Fang,Xiaoxue Long,Xiaolin Wang,Yanli Li,Yaorui Ye,Jianping Ye,Yuqian Bao,Yueliang Zhao,Guowang Xu,Xinyu Liu,Gianni Panagiotou,Aimin Xu,Weiping Jia

DOI: https://doi.org/10.1038/s42255-024-00988-y

IF: 19.865

2024-01-01

Nature Metabolism

Abstract:Emerging evidence suggests that modulation of gut microbiota by dietary fibre may offer solutions for metabolic disorders. In a randomized placebo-controlled crossover design trial (ChiCTR-TTRCC-13003333) in 37 participants with overweight or obesity, we test whether resistant starch (RS) as a dietary supplement influences obesity-related outcomes. Here, we show that RS supplementation for 8 weeks can help to achieve weight loss (mean −2.8 kg) and improve insulin resistance in individuals with excess body weight. The benefits of RS are associated with changes in gut microbiota composition. Supplementation with Bifidobacterium adolescentis , a species that is markedly associated with the alleviation of obesity in the study participants, protects male mice from diet-induced obesity. Mechanistically, the RS-induced changes in the gut microbiota alter the bile acid profile, reduce inflammation by restoring the intestinal barrier and inhibit lipid absorption. We demonstrate that RS can facilitate weight loss at least partially through B. adolescentis and that the gut microbiota is essential for the action of RS.
The potential of resistant starch as a prebiotic

Siti A. Zaman,Shahrul R. Sarbini

DOI: https://doi.org/10.3109/07388551.2014.993590

IF: 9.062

2015-01-13

Critical Reviews in Biotechnology

Abstract:Resistant starch is defined as the total amount of starch and the products of starch degradation that resists digestion in the small intestine. Starches that were able to resist the digestion will arrive at the colon where they will be fermented by the gut microbiota, producing a variety of products which include short chain fatty acids that can provide a range of physiological benefits. There are several factors that could affect the resistant starch content of a carbohydrate which includes the starch granule morphology, the amylose-amylopectin ratio and its association with other food component. One of the current interests on resistant starch is their potential to be used as a prebiotic, which is a non-digestible food ingredient that benefits the host by stimulating the growth or activity of one or a limited number of beneficial bacteria in the colon. A resistant starch must fulfill three criterions to be classified as a prebiotic; resistance to the upper gastrointestinal environment, fermentation by the intestinal microbiota and selective stimulation of the growth and/or activity of the beneficial bacteria. The market of prebiotic is expected to reach USD 198 million in 2014 led by the export of oligosaccharides. Realizing this, novel carbohydrates such as resistant starch from various starch sources can contribute to the advancement of the prebiotic industry.

biotechnology & applied microbiology
Role of resistant starch in improving gut health, adiposity, and insulin resistance.

Diana B Coulon,C. Pelkman,Roy J Martin,M. Keenan,M. Hegsted,Holiday A. Durham,June Zhou

DOI: https://doi.org/10.3945/an.114.007419

IF: 9.3

2015-03-01

Advances in Nutrition

Abstract:The realization that low-glycemic index diets were formulated using resistant starch led to more than a decade of research on the health effects of resistant starch. Determination of the metabolizable energy of the resistant starch product allowed for the performance of isocaloric studies. Fermentation of resistant starch in rodent studies results in what appears to be a healthier gut, demonstrated by increased amounts of short-chain fatty acids, an apparent positive change in the microbiota, and increased gene expression for gene products involved in normal healthy proliferation and apoptosis of potential cancer cells. Additionally, consumption of resistant starch was associated with reduced abdominal fat and improved insulin sensitivity. Increased serum glucagon-like peptide 1 (GLP-1) likely plays a role in promoting these health benefits. One rodent study that did not use isocaloric diets demonstrated that the use of resistant starch at 8% of the weight of the diet reduced body fat. This appears to be approximately equivalent to the human fiber requirement. In human subjects, insulin sensitivity is increased with the feeding of resistant starch. However, only 1 of several studies reports an increase in serum GLP-1 associated with resistant starch added to the diet. This means that other mechanisms, such as increased intestinal gluconeogenesis or increased adiponectin, may be involved in the promotion of improved insulin sensitivity. Future research may confirm that there will be improved health if human individuals consume the requirement for dietary fiber and a large amount of the fiber is fermentable.

Biology,Medicine,Agricultural and Food Sciences
Effect of Dietary Resistant Starch on Prevention and Treatment of Obesity-related Diseases and Its Possible Mechanisms.

Zhang Lei,Li Hua Ting,Shen Li,Fang Qi Chen,Ling,Jia Wei Ping

DOI: https://doi.org/10.3967/bes2015.040

2015-01-01

Abstract:Overweight or obesity has become a serious public health problem in the world, scientists are concentrating their efforts on exploring novel ways to treat obesity. Nowadays, the availabilities of bariatric surgery and pharmacotherapy have enhanced obesity treatment, but it should has support from diet, physical exercise and lifestyle modification, especially the functional food. Resistant starch, an indigestible starch, has been studied for years for its beneficial effects on regulating blood glucose level and lipid metabolism. The aim of this review is to summarize the effect of resistant starch on weight loss and the possible mechanisms. According to numerous previous studies it could be concluded that resistant starch can reduce fat accumulation, enhance insulin sensitivity, regulate blood glucose level and lipid metabolism. Recent investigations have focused on the possible associations between resistant starch and incretins as well as gut microbiota. Resistant starch seems to be a promising dietary fiber for the prevention or treatment of obesity and its related diseases.
The effect of inulin and resistant maltodextrin on weight loss during energy restriction: a randomised, placebo-controlled, double-blinded intervention

Anne Lundby Hess,Alfonso Benítez-Páez,Trine Blædel,Lesli Hingstrup Larsen,Jose Ramón Iglesias,Carmen Madera,Yolanda Sanz,Thomas Meinert Larsen,MyNewGut Consortium

DOI: https://doi.org/10.1007/s00394-019-02099-x

Abstract:Purpose: The objective of this study was to investigate the additive effects of combining energy restriction with dietary fibres on change in body weight and gut microbiota composition. Methods: The study was a 12-week randomised, placebo-controlled, double-blinded, parallel intervention trial. A total of 116 overweight or obese participants were assigned randomly either to 10 g inulin plus 10 g resistant maltodextrin or to 20 g of placebo supplementation through 400 mL of milk a day, while on a - 500 kcal/day energy restricted diet. Results: Altogether, 86 participants completed the intervention. There were no significant differences in weight loss or body composition between the groups. The fibre supplement reduced systolic (5.35 ± 2.4 mmHg, p = 0.043) and diastolic (2.82 ± 1.3 mmHg, p = 0.047) blood pressure to a larger extent than placebo. Furthermore, a larger decrease in serum insulin was observed in the placebo group compared to the fibre group (- 26.0 ± 9.2 pmol/L, p = 0.006). The intake of fibre induced changes in the composition of gut microbiota resulting in higher abundances of Parabacteroides and Bifidobacteria, compared to placebo. The effects on blood pressure and glucose metabolism were mainly observed in women, and could be attributed to a higher gut microbiota diversity after intervention. Finally, the fibre group experienced a higher degree of gastrointestinal symptoms, which attenuated over time. Conclusions: Supplementation of inulin and resistant maltodextrin did not provide an additional weight loss during an energy-restricted diet, but reduced both systolic and diastolic blood pressure. Furthermore, the fibre supplement did stimulate the growth of potentially beneficial bacteria genera. Clinical trial registry: The study was registered at http://www.clinicaltrials.gov , NCT03135041.
Resistant Starch and Energy Balance: Impact on Weight Loss and Maintenance

Janine A. Higgins

DOI: https://doi.org/10.1080/10408398.2011.629352

IF: 11.208

2014-01-01

Critical Reviews in Food Science and Nutrition

Abstract:The obesity epidemic has prompted researchers to find effective weight-loss and maintenance tools. Weight loss and subsequent maintenance are reliant on energy balance--the net difference between energy intake and energy expenditure. Negative energy balance, lower intake than expenditure, results in weight loss whereas positive energy balance, greater intake than expenditure, results in weight gain. Resistant starch has many attributes, which could promote weight loss and/or maintenance including reduced postprandial insulinemia, increased release of gut satiety peptides, increased fat oxidation, lower fat storage in adipocytes, and preservation of lean body mass. Retention of lean body mass during weight loss or maintenance would prevent the decrease in basal metabolic rate and, therefore, the decrease in total energy expenditure, that occurs with weight loss. In addition, the fiber-like properties of resistant starch may increase the thermic effect of food, thereby increasing total energy expenditure. Due to its ability to increase fat oxidation and reduce fat storage in adipocytes, resistant starch has recently been promoted in the popular press as a "weight loss wonder food". This review focuses on data describing the effects of resistant starch on body weight, energy intake, energy expenditure, and body composition to determine if there is sufficient evidence to warrant these claims.

food science & technology,nutrition & dietetics
Health benefits of resistant starch: A review of the literature

Adrianna Bojarczuk,Sylwia Skąpska,Amin Mousavi Khaneghah,Krystian Marszałek

DOI: https://doi.org/10.1016/j.jff.2022.105094

IF: 5.6

2022-06-01

Journal of Functional Foods

Abstract:Starch is an essential source of energy for the human diet. Resistant starch is the portion of starch that is not digested in the small intestine and is fermented in the colon by microorganisms, resulting in the formation of short-chain fatty acids, which may be associated with some metabolic effects. In this regard, this review aims to present relevant research on the health benefits of consuming resistant starch and its effects on physiological properties such as intestinal health, glycemic balance, lipid metabolism, and body weight to be evaluated. However, the effect of resistant starch in reducing the risk of diet-dependent disorders such as diabetes, obesity, lipid disorders, and intestinal health is promising but still inconclusive.

food science & technology,nutrition & dietetics
Evidence Mapping: Resistant Starch Interventions and Health Outcomes

Caleigh M Sawicki,Vrushabh Shah,Kara A Livingston,Susan B Roberts,Mei Chung,Nicola M McKeown

DOI: https://doi.org/10.1096/fasebj.30.1_supplement.1154.26

2016-04-01

The FASEB Journal

Abstract:Resistant starch has potential health benefits including improving glycemic control, increasing satiety, and gut health. The aim of this project was to use evidence mapping methodology to summarize published data on the relationship between resistant starch consumption and several physiological health outcomes. A newly developed fiber database, comprised of human intervention studies published from 1946 to September 2013, identified 76 publications detailing dietary interventions using resistant starch. Within the 76 publications, 104 resistant starch interventions were identified, which varied widely in description of type and/or source of resistant starch. Descriptive analyses were performed to summarize study design characteristics, exposures, and outcomes, and weighted scatter plots were used to visualize gaps in the current body of research. The majority of studies were randomized crossover designs (74%) in adult populations (92%). The physiological health outcomes most frequently studied were colonic fermentation/short chain fatty acid production (17%), postprandial glucose and insulin metabolism (16%), and fecal bulking/laxation (10%). There was little available information on blood pressure, blood lipids, and transit time. Only 7 studies (9%) had a sample size of more than 50 subjects, and 37% of interventions were acute studies that lasted less than 2 days. The effect of resistant starch on health outcomes among overweight, obese, or metabolically at‐risk subjects is lacking, reported in only 19% of studies. Moving forward, dietary intervention studies examining the effect of different resistant starches could be of longer duration in a wider range of subjects and health outcomes, and a meta‐analysis could be employed to synthesize the research and strengthen the cumulative evidence on this topic. Support or Funding Information This project was supported by a grant from the International Life Science Institute ‐ North America Branch, Technical Committee on Carbohydrates

cell biology,biochemistry & molecular biology,biology
Effect of Resistant Dextrin on Intestinal Gas Homeostasis and Microbiota

Claudia Barber,Carlos Sabater,María Ángeles Ávila-Gálvez,Fernando Vallejo,Rogger Alvaro Bendezu,Laetitia Guérin-Deremaux,Francisco Guarner,Juan Carlos Espín,Abelardo Margolles,Fernando Azpiroz

DOI: https://doi.org/10.3390/nu14214611

IF: 5.9

2022-11-03

Nutrients

Abstract:Previous studies have shown that a resistant dextrin soluble fibre has prebiotic properties with related health benefits on blood glucose management and satiety. Our aim was to demonstrate the effects of continuous administration of resistant dextrin on intestinal gas production, digestive sensations, and gut microbiota metabolism and composition. Healthy subjects (n = 20) were given resistant dextrin (14 g/d NUTRIOSE®, Roquette Frères, Lestrem, France) for four weeks. Outcomes were measured before, at the beginning, end, and two weeks after administration: anal evacuations of gas during daytime; digestive perception, girth, and gas production in response to a standard meal; sensory and digestive responses to a comfort meal; volume of colonic biomass by magnetic resonance; taxonomy and metabolic functions of fecal microbiota by shotgun sequencing; metabolomics in urine. Dextrin administration produced an initial increase in intestinal gas production and gas-related sensations, followed by a subsequent decrease, which magnified after discontinuation. Dextrin enlarged the volume of colonic biomass, inducing changes in microbial metabolism and composition with an increase in short chain fatty acids-producing species and modulation of bile acids and biotin metabolism. These data indicate that consumption of a soluble fibre induces an adaptative response of gut microbiota towards fermentative pathways with lower gas production.

nutrition & dietetics
Resident gut microbiota community determines the efficacy of soluble fiber in reducing adiposity

Swang M. Shallangwa,Alexander W. Ross,Alan W. Walker,Peter J. Morgan

DOI: https://doi.org/10.3389/fmicb.2024.1392016

IF: 5.2

2024-04-30

Frontiers in Microbiology

Abstract:Consumption of dietary fiber has been linked to several health benefits. Among these, dietary fiber breakdown through the process of anaerobic fermentation by the colonic microbiota leads to the production of beneficial metabolites, mainly short-chain fatty acids (acetate, propionate, and butyrate), which have been implicated in reduced calorie intake. Nevertheless, the link between gut microbiota and obesity remains unclear. We investigated the effects of dietary fibers on food intake and body weight gain in two independent but similarly designed studies in rats. In the first study, the inclusion of 10% w/w pectin, fructooligosaccharides or beta-glucan ( n = 10/group) in the diets each significantly reduced body weight gain ( ' responders ' ) compared to the cellulose control whereas, in a closely matched, but not fully identical study ( n = 8/group), no effect of dietary fiber on body weight ( ' non-responders' ) was observed. The aim of this work was to explore the basis of this differential response between the two similarly designed and comparable studies, with a focus on the potential role of the gut microbiota in the control of food intake and body weight.

microbiology
Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial

Anouck Becker,Georges Pierre Schmartz,Laura Gröger,Nadja Grammes,Valentina Galata,Hannah Philippeit,Jacqueline Weiland,Nicole Ludwig,Eckart Meese,Sascha Tierling,Jörn Walter,Andreas Schwiertz,Jörg Spiegel,Gudrun Wagenpfeil,Klaus Faßbender,Andreas Keller,Marcus M Unger

DOI: https://doi.org/10.1016/j.gpb.2021.08.009

Abstract:The composition of the gut microbiota is linked to multiple diseases, including Parkinson's disease (PD). Abundance of bacteria producing short-chain fatty acids (SCFAs) and fecal SCFA concentrations are reduced in PD. SCFAs exert various beneficial functions in humans. In the interventional, monocentric, open-label clinical trial "Effects of Resistant Starch on Bowel Habits, Short Chain Fatty Acids and Gut Microbiota in Parkinson'sDisease" (RESISTA-PD; ID: NCT02784145), we aimed at altering fecal SCFAs by an 8-week prebiotic intervention with resistant starch (RS). We enrolled 87 subjects in three study-arms: 32 PD patients received RS (PD + RS), 30 control subjects received RS, and 25 PD patients received solely dietary instructions. We performed paired-end 100 bp length metagenomic sequencing of fecal samples using the BGISEQ platform at an average of 9.9 GB. RS was well-tolerated. In the PD + RS group, fecal butyrate concentrations increased significantly, and fecal calprotectin concentrations dropped significantly after 8 weeks of RS intervention. Clinically, we observed a reduction in non-motor symptom load in the PD + RS group. The reference-based analysis of metagenomes highlighted stable alpha-diversity and beta-diversity across the three groups, including bacteria producing SCFAs. Reference-free analysis suggested punctual, yet pronounced differences in the metagenomic signature in the PD + RS group. RESISTA-PD highlights that a prebiotic treatment with RS is safe and well-tolerated in PD. The stable alpha-diversity and beta-diversity alongside altered fecal butyrate and calprotectin concentrations call for long-term studies, also investigating whether RS is able to modify the clinical course of PD.
An In-Depth Overview of the Structural Properties, Health Benefits, and Applications of Resistant Dextrin

Xiuli Wu,Jianwen Zhang,Xiangxuan Yan,Xuexu Wu,Qing Zhang,Mingran Luan

DOI: https://doi.org/10.1155/2024/8055063

2024-04-16

Journal of Food Processing and Preservation

Abstract:With the escalating prevalence of diabetes and obesity, resistant dextrin, renowned for its prebiotic properties and blood glucose-lowering physiological activity, has garnered significant attention. Resistant dextrin, a low-calorie, indigestible water-soluble dietary fiber processed from starch, has high solubility, low molecular weight, and good thermal stability. The established method for its preparation involves a combination of acid heat treatment and enzymatic purification. Within the human body, resistant dextrin confers numerous health benefits. It promotes a balanced intestinal microbiome, regulates blood glucose and lipid metabolism, and enhances satiety. Additionally, it exerts positive influences on the intestinal environment, aids in weight management, and alleviates chronic conditions, particularly diabetes. In the food industry, resistant dextrin is widely employed as a functional food additive to enhance the nutritional value and health benefits of various food products. However, there is a need for greater clarity regarding the structural characteristics of resistant dextrin and the potential interplay between its structure and physiological activity. This paper comprehensively reviews the preparation methods, structural properties, health benefits, and application areas of resistant dextrin. Additionally, it anticipates future trends in its development. The primary objective of this review is to offer theoretical guidance and fresh perspectives for further research, the innovation of functional products, and the expanded utilization of resistant dextrin.

food science & technology
Impact of a resistant dextrin on intestinal ecology: how altering the digestive ecosystem with NUTRIOSE®, a soluble fibre with prebiotic properties, may be beneficial for health

C Lefranc-Millot,L Guérin-Deremaux,D Wils,C Neut,L E Miller,M H Saniez-Degrave

DOI: https://doi.org/10.1177/147323001204000122

Abstract:Objectives: The prebiotic potential of NUTRIOSE®--a sugar-free, digestion-resistant dextrin--was evaluated in two randomized, placebo-controlled trials that included 48 and 40 healthy volunteers, respectively. Methods: In study 1, the effect on colonic bacteria of NUTRIOSE® 10, 15 or 20 g/day administered for 14 days was examined; in study 2, gut microbial changes in response to NUTRIOSE® 8 g/day for 14 days were monitored using real-time polymerase chain reaction analysis. Results: NUTRIOSE® increased proliferation of Bacteroides and inhibited Clostridum perfringens in both studies, increased β-glucosidase activity (at 10 and 15 g/day) and decreased colonic pH (at 20 g/day). The increase in short-chain fatty acid production with NUTRIOSE® consumption was not statistically significant. There were no indications of gastrointestinal intolerance at any dose. Conclusions: According to commonly accepted definitions, NUTRIOSE® is a prebiotic soluble fibre that provides a beneficial effect on colonic ecology while preserving digestive comfort.
Resistant starch-enriched brown rice exhibits prebiotic properties and enhances gut health in obese mice

Miri Park,Hye-Bin Lee,Ha Ram Kim,Min-Cheol Kang,Duyun Jeong,Hee-Don Choi,Jung Sun Hong,Ho-Young Park

DOI: https://doi.org/10.1016/j.foodres.2024.114417

Abstract:Resistant starch serves as a prebiotic in the large intestine, aiding in the maintenance of a healthy intestinal environment and mitigating associated chronic illnesses. This study aimed to investigate the impact of resistant starch-enriched brown rice (RBR) on intestinal health and functionality. We assessed changes in resistant starch concentration, structural alterations, and branch chain length distribution throughout the digestion process using an in vitro model. The efficacy of RBR in the intestinal environment was evaluated through analyses of its prebiotic potential, effects on intestinal microbiota, and intestinal function-related proteins in obese animals fed a high-fat diet. RBR exhibited a higher yield of insoluble fraction in both the small and large intestines compared to white and brown rice. The total digestible starch content decreased, while the resistant starch content significantly increased during in vitro digestion. Furthermore, RBR notably enhanced the growth of four probiotic strains compared to white and brown rice, displaying higher proliferation activity than the positive control, FOS. Notably, consumption of RBR by high-fat diet-induced obese mice suppressed colon shortening, increased Bifidobacteria growth, and improved intestinal permeability. These findings underscore the potential prebiotic and gut health-promoting attributes of RBR, offering insights for the development of functional foods aimed at preventing gastrointestinal diseases.
Resistant starch, microbiome, and precision modulation

Peter A. Dobranowski,Alain Stintzi

DOI: https://doi.org/10.1080/19490976.2021.1926842

IF: 12.2

2021-01-01

Gut Microbes

Abstract:Resistant starch, microbiome, and precision modulation. Mounting evidence has positioned the gut microbiome as a nexus of health. Modulating its phylogenetic composition and function has become an attractive therapeutic prospect. Resistant starches (granular amylase-resistant α-glycans) are available as physicochemically and morphologically distinguishable products. Attempts to leverage resistant starch as microbiome-modifying interventions in clinical studies have yielded remarkable inter-individual variation. Consequently, their utility as a potential therapy likely depends predominantly on the selected resistant starch and the subject's baseline microbiome. The purpose of this review is to detail i) the heterogeneity of resistant starches, ii) how resistant starch is sequentially degraded and fermented by specialized gut microbes, and iii) how resistant starch interventions yield variable effects on the gut microbiome.

gastroenterology & hepatology,microbiology
Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial

Audrey M Neyrinck,Julie Rodriguez,Zhengxiao Zhang,Benjamin Seethaler,Cándido Robles Sánchez,Martin Roumain,Sophie Hiel,Laure B Bindels,Patrice D Cani,Nicolas Paquot,Miriam Cnop,Julie-Anne Nazare,Martine Laville,Giulio G Muccioli,Stephan C Bischoff,Jens Walter,Jean-Paul Thissen,Nathalie M Delzenne

DOI: https://doi.org/10.1007/s00394-021-02484-5

Abstract:Purpose: Inulin-type fructans (ITF) are prebiotic dietary fibre (DF) that may confer beneficial health effects, by interacting with the gut microbiota. We have tested the hypothesis that a dietary intervention promoting inulin intake versus placebo influences fecal microbial-derived metabolites and markers related to gut integrity and inflammation in obese patients. Methods: Microbiota (16S rRNA sequencing), long- and short-chain fatty acids (LCFA, SCFA), bile acids, zonulin, and calprotectin were analyzed in fecal samples obtained from obese patients included in a randomized, placebo-controlled trial. Participants received either 16 g/d native inulin (prebiotic n = 12) versus maltodextrin (placebo n = 12), coupled to dietary advice to consume inulin-rich versus inulin-poor vegetables for 3 months, in addition to dietary caloric restriction. Results: Both placebo and prebiotic interventions lowered energy and protein intake. A substantial increase in Bifidobacterium was detected after ITF treatment (q = 0.049) supporting our recent data obtained in a larger cohort. Interestingly, fecal calprotectin, a marker of gut inflammation, was reduced upon ITF treatment. Both prebiotic and placebo interventions increased the ratio of tauro-conjugated/free bile acids in feces. Prebiotic treatment did not significantly modify fecal SCFA content but it increased fecal rumenic acid, a conjugated linoleic acid (cis-9, trans-11 CLA) with immunomodulatory properties, that correlated notably to the expansion of Bifidobacterium (p = 0.031; r = 0.052). Conclusions: Our study demonstrates that ITF-prebiotic intake during 3 months decreases a fecal marker of intestinal inflammation in obese patients. Our data point to a potential contribution of microbial lipid-derived metabolites in gastro-intestinal dysfunction related to obesity. CLINICALTRIALS. Gov identifier: NCT03852069 (February 22, 2019 retrospectively, registered).
Resistant starch: metabolic effects and potential health benefits

Janine A Higgins

Abstract:Although there is strong evidence that the amount and type of fat in the diet can have dramatic effects on metabolism, the case for carbohydrate subtypes influencing metabolic parameters is emerging. By definition, resistant starch (RS) is any starch that is not digested in the small intestine but passes to the large bowel. Here, RS is a good substrate for fermentation which gives rise to an increase in short-chain fatty acid production. The differing rates of absorption between RS and digestible starch are thought to denote their differential metabolic responses. RS intake is associated with several changes in metabolism which may confer some health benefits. RS intake seems to decrease postprandial glycemic and insulinemic responses, lower plasma cholesterol and triglyceride concentrations, improve whole body insulin sensitivity, increase satiety, and reduce fat storage. These properties make RS an attractive dietary target for the prevention of diseases associated with dyslipidemia and insulin resistance as well as the development of weight loss diets and dietary therapies for the treatment of Type 2 diabetes and coronary heart disease. This review analyzes the body of literature examining the metabolic effects of RS consumption and discusses possible mechanisms whereby increased short-chain fatty acid production in the bowel could account for some of these effects. The effects of RS in the large bowel per se are the topic of other reviews and are not addressed in this paper.
Physiological Effects of Resistant Starches on Fecal Bulk, Short Chain Fatty Acids, Blood Lipids and Glycemic Index

David J.A. Jenkins,Vladimir Vuksan,Cyril W.C. Kendall,Pierre Würsch,Roger Jeffcoat,Susan Waring,Christine C. Mehling,Edward Vidgen,Livia S.A. Augustin,Evelyn Wong,Pierre Würsch

DOI: https://doi.org/10.1080/07315724.1998.10718810

1998-12-01

Journal of the American College of Nutrition

Abstract:OBJECTIVE: To assess the effects on fecal bulking, fecal short chain fatty acid (SCFA) production, blood lipids and glycemic indices of two different forms of resistant starch (RS2 and RS3) from a high-amylose cornstarch.METHODS: Twenty-four healthy subjects (12 men; 12 women) consumed four supplements taken for 2 weeks in random order separated by 2-week washout periods. The supplements were a low-fiber (control) and supplements providing an additional 30 g dietary fiber as wheat bran (high-fiber control) or the equivalent amount of resistant starch analyzed gravimetrically as dietary fiber from RS2 or RS3. Four-day fecal collections and 12-hour breath gas collections were obtained at the end of each period. Fasting blood was taken at the beginning and end of each period. Glycemic indices of supplements were also assessed.RESULTS: The wheat bran supplement increased fecal bulk 96+/-14 g/day compared with the low-fiber control (p<0.001) with the mean for both resistant starches also being greater (22+/-8 g/day) than the low-fiber control (p=0.013). On the resistant starch phases, the mean fecal butyrate:SCFA ratio, which has been suggested to have positive implications for colonic health, was significantly above the low-fiber control by 31+/-14% (p=0.035). Resistant starches did not alter serum lipids, urea or breath H2 or CH4. No significant differences in glycemic index were seen between the RS and control supplements.CONCLUSION: The potential physiological benefits of the resistant starches studied appear to relate to colonic health in terms of effects on fecal bulk and SCFA metabolism.

nutrition & dietetics
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation

Sri Lakshmi Sravani Devarakonda,Dorothy K. Superdock,Jennifer Ren,Lynn M. Johnson,Aura (Alex) P. Loinard-González,Angela C. Poole

DOI: https://doi.org/10.1080/19490976.2024.2367301

IF: 12.2

2024-06-25

Gut Microbes

Abstract:Resistant starch (RS) consumption can have beneficial effects on metabolic health, but the response, in terms of effects on the gut microbiota and host physiology, varies between individuals. Factors predicting the response to RS are not yet established and would be useful for developing precision nutrition approaches that maximize the benefits of dietary fiber intake. We sought to identify predictors of gut microbiota response to RS supplementation. We enrolled 76 healthy adults into a 7-week crossover study with 59 individuals completing the study. Participants consumed RS type 2 (RS2), RS type 4 (RS4), and digestible starch, for 10 d each with 5-d washout periods in between. We collected fecal and saliva samples and food records during each treatment period. We performed 16S rRNA gene sequencing and measured fecal short-chain fatty acids (SCFAs), salivary amylase ( AMY1 ) gene copy number, and salivary amylase activity (SAA). Dietary fiber intake was predictive of the relative abundance of several amplicon sequence variants (ASVs) at the end of both RS treatments. AMY1 -related metrics were not predictive of response to RS. SAA was only predictive of the relative abundance of one ASV after digestible starch supplementation. Interestingly, SCFA concentrations increased the most during digestible starch supplementation. Treatment order (the order of consumption of RS2 and RS4), alpha diversity, and a subset of ASVs were predictive of SCFA changes after RS supplementation. Based on our findings, dietary fiber intake and gut microbiome composition would be informative if assessed prior to recommending RS supplementation because these data can be used to predict changes in specific ASVs and fecal SCFA concentrations. These findings lay a foundation to support the premise that using a precision nutrition approach to optimize the benefits of dietary fibers such as RS could be an effective strategy to compensate for the low consumption of dietary fiber nationwide.

gastroenterology & hepatology,microbiology
Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity, and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial

Caitlin Victoria Hall,John Luke Twelves,Manish Saxena,Leonardo Scapozza,Thomas Gurry

DOI: https://doi.org/10.1017/s0007114524000904

2024-04-25

British Journal Of Nutrition

Abstract:Prebiotic fibre represents a promising and efficacious treatment to manage pre-diabetes, acting via complementary pathways involving the gut microbiome and viscosity-related properties. In this study, we evaluated the effect of using a diverse prebiotic fibre supplement on glycaemic, lipid, and inflammatory biomarkers in patients with pre-diabetes. Sixty-six patients diagnosed with pre-diabetes (yet not receiving glucose-lowering medications) were randomised into treatment (n = 33) and placebo (n = 33) interventions. Participants in the treatment arm consumed 20g per day of a diverse prebiotic fibre supplement and participants in the placebo arm consumed 2g per day of cellulose for 24 weeks. A total of 51 and 48 participants completed the week 16 and week 24 visits, respectively. The intervention was well-tolerated, with a high average adherence rate across groups. Our results extend upon previous work, showing a significant change in glycated haemoglobin (HbA1c) in the treatment group, but only in participants with lower baseline HbA1c levels (<6% HbA1c) (P = 0.05; treatment -0.17 ± 0.27 vs. placebo 0.07 ± 0.29, mean ± SD). Within the whole cohort, we showed significant improvements in insulin sensitivity (P = 0.03; treatment 1.62 ± 5.79 v. placebo -0.77 ± 2.11), and C-reactive protein (P FWE = 0.03; treatment -2.02 ± 6.42 vs placebo 0.94 ± 2.28) in the treatment group compared with the placebo. Together, our results support the use of a diverse prebiotic fibre supplement for physiologically relevant biomarkers in pre-diabetes.

nutrition & dietetics

Resisting weight gain with prebiotic fibre

Resistant Starch Intake Facilitates Weight Loss in Humans by Reshaping the Gut Microbiota

The potential of resistant starch as a prebiotic

Role of resistant starch in improving gut health, adiposity, and insulin resistance.

Effect of Dietary Resistant Starch on Prevention and Treatment of Obesity-related Diseases and Its Possible Mechanisms.

The effect of inulin and resistant maltodextrin on weight loss during energy restriction: a randomised, placebo-controlled, double-blinded intervention

Resistant Starch and Energy Balance: Impact on Weight Loss and Maintenance

Health benefits of resistant starch: A review of the literature

Evidence Mapping: Resistant Starch Interventions and Health Outcomes

Effect of Resistant Dextrin on Intestinal Gas Homeostasis and Microbiota

Resident gut microbiota community determines the efficacy of soluble fiber in reducing adiposity

Effects of Resistant Starch on Symptoms, Fecal Markers, and Gut Microbiota in Parkinson's Disease - The RESISTA-PD Trial

An In-Depth Overview of the Structural Properties, Health Benefits, and Applications of Resistant Dextrin

Impact of a resistant dextrin on intestinal ecology: how altering the digestive ecosystem with NUTRIOSE®, a soluble fibre with prebiotic properties, may be beneficial for health

Resistant starch-enriched brown rice exhibits prebiotic properties and enhances gut health in obese mice

Resistant starch, microbiome, and precision modulation

Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial

Resistant starch: metabolic effects and potential health benefits

Physiological Effects of Resistant Starches on Fecal Bulk, Short Chain Fatty Acids, Blood Lipids and Glycemic Index

Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation

Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity, and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial